Please use this identifier to cite or link to this item:
|Title:||Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma.|
Choy, D. F.
Ohri, C. M.
Abbas, A. R.
Austin, C. D.
Wu, L. C.
Heaney, L. G.
Arron, J. R.
|Citation:||Journal of Allergy and Clinical Immunology, 2012, 129 (1), pp. 104-11.e1-9-104-11.e1-9|
|Abstract:||Thymic stromal lymphopoietin (TSLP) is a cytokine implicated in the pathophysiology of asthma through 2 distinct pathways: a TSLP-OX40 ligand (OX40L)-T cell axis and a TSLP-mast cell axis. Whether these pathways are active in human asthma is unknown.|
|Appears in Collections:||Published Articles, Dept. of Infection, Immunity and Inflammation|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.